KALDYUM toimeainet prolongeeritult vabastav kõvakapsel Eesti - eesti - Ravimiamet

kaldyum toimeainet prolongeeritult vabastav kõvakapsel

egis pharmaceuticals plc - kaaliumkloriid - toimeainet prolongeeritult vabastav kõvakapsel - 600mg 100tk; 600mg 50tk

MONOKALIUMFOSFAT B.BRAUN infusioonilahuse kontsentraat Eesti - eesti - Ravimiamet

monokaliumfosfat b.braun infusioonilahuse kontsentraat

b.braun melsungen ag - kaaliumdivesinikfosfaat - infusioonilahuse kontsentraat - 136mg 1ml 20ml 20tk

KALIUM CHLORATUM WZF 15% infusioonilahuse kontsentraat Eesti - eesti - Ravimiamet

kalium chloratum wzf 15% infusioonilahuse kontsentraat

warsaw pharmaceutical works polfa s.a. - kaaliumkloriid - infusioonilahuse kontsentraat - 150mg 1ml 10ml 50tk

Imatinib Accord Euroopa Liit - eesti - EMA (European Medicines Agency)

imatinib accord

accord healthcare s.l.u. - imatiniib - precursor cell lymphoblastic leukemia-lymphoma; dermatofibrosarcoma; myelodysplastic-myeloproliferative diseases; leukemia, myelogenous, chronic, bcr-abl positive; hypereosinophilic syndrome - imatiniib - imatinib accord is indicated for the treatment of- adult and paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment. - adult and paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis. - adult and paediatric patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy. - adult patients with relapsed or refractory ph+ all as monotherapy. - adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements. - adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfrα rearrangement. - adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. - the treatment of adult patients with kit (cd 117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). - the adjuvant treatment of adult patients who are at significant risk of relapse following resection of kit (cd117)-positive gist. patients who have a low or very low risk of recurrence should not receive adjuvant treatmentthe effect of imatinib on the outcome of bone marrow transplantation has not been determined. in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. the experience with imatinib in patients with mds/mpd associated with pdgfr gene re-arrangements is very limited (see section 5. välja arvatud äsja diagnoositud kroonilise faasi cml, ei ole kontrollitud uuringud, mis näitab kliiniline kasu või suurenenud ellujäämise eest need haigused. .

LOSARTAN/HYDROCHLOROTHIAZIDE IPCA õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

losartan/hydrochlorothiazide ipca õhukese polümeerikattega tablett

ipca produtos farmaceuticos unipessoal lda - losartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 50mg+12,5mg 98tk; 50mg+12,5mg 14tk; 50mg+12,5mg 56tk; 50mg+12,5mg 28tk

Prialt Euroopa Liit - eesti - EMA (European Medicines Agency)

prialt

esteve pharmaceuticals gmbh - zikonotiid - injections, spinal; pain - valuvaigistid - zikonotiid on näidustatud raske, kroonilise valu raviks patsientidel, kes vajavad intratekaalset (it) analgeesiat.

VILDAGLIPTIN/METFORMIN TEVA õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

vildagliptin/metformin teva õhukese polümeerikattega tablett

teva b.v. - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 60tk

VILDAGLIPTIN/METFORMIN TEVA õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

vildagliptin/metformin teva õhukese polümeerikattega tablett

teva b.v. - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 30tk; 1000mg+50mg 12tk; 1000mg+50mg 60tk

MOFENSTRA õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

mofenstra õhukese polümeerikattega tablett

sandoz pharmaceuticals d.d. - montelukast - õhukese polümeerikattega tablett - 10mg 21tk; 10mg 200tk; 10mg 28tk; 10mg 60tk; 10mg 90tk; 10mg 98tk; 10mg 49tk; 10mg 56tk; 10mg 140tk; 10mg 50tk; 10mg 100tk; 10mg 20tk; 10mg 250tk; 10mg 10tk; 10mg 84tk; 10mg 7tk; 10mg 14tk; 10mg 30tk

KALII CHLORIDUM/NATRII CHLORIDUM B. BRAUN 3 MG/ML + 9 MG/ML infusioonilahus Eesti - eesti - Ravimiamet

kalii chloridum/natrii chloridum b. braun 3 mg/ml + 9 mg/ml infusioonilahus

b. braun melsungen ag - elektrolüüdid - infusioonilahus - 1000ml 10tk; 500ml 10tk